Skip to main content
NACFC 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session
Back

NRS

CLIN
Workshop

W36--Endocrine Screening - What You Need to Know

Saturday, September 28, 2024
10:15 AM – 12:15 PM ET
Location:104 AB

Recorded Session

Endocrine disorders are common comorbidities for persons with cystic fibrosis. Endocrine comorbidities include bone disease, diabetes, impaired glucose tolerance, and hormonal changes in aging. Up to one-third of adults with cystic fibrosis have bone disease and up to 20% of adolescents and 40% of adults with cystic fibrosis have diabetes. Identification and treatment of these disorders are important components of caring for patients with cystic fibrosis. This session will explore screening options for cystic fibrosis-related diabetes, bone disease, and menopause.

Learning Objectives:

  • Identify symptoms associated with menopause and recognize menopause treatment options.
  • Understand the need for bone disease and diabetes screening in cystic fibrosis patients, including those benefitting from highly effective modulator therapy.
  • Describe effective screening modalities for bone disease and diabetes in persons with cystic fibrosis, including potential alternatives to the current practice.